Top news of the week: 27.04.2022.
Companies And Industries
KBI Biopharma Holds Ribbon Cutting for New Commercial Manufacturing Facility
KBI Biopharma Holds Ribbon Cutting for New Commercial Manufacturing Facility; Expands US-based mammalian cell culture operations
Biotechs Turn to M&A as Liquidity Surges and Market Caps Falter
Biotech companies are facing sharp declines in stock prices, while venture capital and private equity are experiencing increases. BDO Life Sciences' Lance Minor sat down BioSpace's Gail ...
The COVID-19 Pandemic will End, with Implications for Biopharma
The COVID-19 pandemic will end one day and, when it does, some biopharma companies will need to revert to a more normal way of working with others.
Sanonia, Black Diamond Fall Victim To Rough Biotech Market
The first quarter hasn't been kind to international biopharmaceutical firms. BioSpace takes a look at the fates of Saniona and Black Diamond below.
Sanofi Strikes Deal With Mysterious Psychedelics Biotech Terran
New York-based Terran Biosciences inked a deal with Paris-based Sanofi for two late-stage central nervous system (CNS) assets. Terran plans to advance them for neurological and ...
In a surprise move, Novartis CEO Vas Narasimhan recruits top analyst Ronny Gal as new strategy, BD chief
After a long run observing Novartis and the rest of the Big Pharma world as a top analyst, Bernstein’s Ronny Gal will now move into the upper echelon of the Swiss giant’s executive crew to ...
Ocugen Sees Ray of Light with Gene Therapy for Retinitis Pigmentosa
The DSMB for Ocugen's Phase I/II trial of OCU400, a gene therapy in development for Retinitis Pigmentosa (RP), recommended the study proceed with enrolling more patients.
Drug developers drop again amid finicky markets
While BioWorld’s Drug Developers Index appeared to be moving in the right direction last month, it did an about-face in April and is now at its lowest point this year, down 23.1%, following ...